After finishing at $2.31 in the prior trading day, Esperion Therapeutics Inc. (NASDAQ: ESPR) closed at $2.14, down -7.36%. On the day, 7526610 shares were traded. ESPR stock price reached its highest trading level at $2.4200 during the session, while it also had its lowest trading level at $2.0400.
Ratios:
Our goal is to gain a better understanding of ESPR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’23 when Warren Eric sold 742 shares for $1.25 per share. The transaction valued at 924 led to the insider holds 68,318 shares of the business.
Warren Eric sold 243 shares of ESPR for $344 on Aug 18 ’23. The Chief Commercial Officer now owns 69,060 shares after completing the transaction at $1.41 per share. On Jul 19 ’23, another insider, Warren Eric, who serves as the Chief Commercial Officer of the company, sold 106 shares for $1.58 each. As a result, the insider received 168 and left with 69,303 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.14.
Stock Price History:
Over the past 52 weeks, ESPR has reached a high of $3.40, while it has fallen to a 52-week low of $0.70.
Shares Statistics:
A total of 170.42M shares are outstanding, with a floating share count of 168.54M. Insiders hold about 1.10% of the company’s shares, while institutions hold 48.11% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Esperion Therapeutics, Inc. different market analysts. The consensus estimate for the next quarter is $40.68, with high estimates of $27.72 and low estimates of $34.27.
Analysts are recommending an EPS of between $Healthcare and $Industrials for the fiscal current year, implying an average EPS of $Real Estate.
